A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

This study has suspended participant recruitment.

(Reassessment of strategic direction)

Sponsor:

Information provided by (Responsible Party):

Enzon Pharmaceuticals, Inc.

ClinicalTrials.gov Identifier:

NCT01337518

First received: April 15, 2011

Last updated: December 17, 2012

Last verified: September 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has suspended participant recruitment.
Estimated Study Completion Date:	December 2013
Estimated Primary Completion Date:	December 2013 (Final data collection date for primary outcome measure)